| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 28,616 | 26,209 | 23,250 | 27,375 | | Cost of Revenue | 18,640 | 16,610 | 15,118 | 16,059 | | | Gross Profit | 9,976 | 9,599 | 8,132 | 11,316 | | | Operating Expenses | | Research Development | 2,498 | 1,868 | 2,052 | 2,263 | | Selling General and Administrative | 7,336 | 6,924 | 7,468 | 7,930 | | Non Recurring | (96) | 315 | 9 | (9) | | Others | 318 | 317 | 318 | 317 | | | | Total Operating Expenses | 10,056 | 9,424 | 9,847 | 10,501 | | | | Operating Income or Loss | (213) | 175 | (1,715) | 815 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (37) | 238 | (403) | (212) | | Earnings Before Interest And Taxes | (117) | 413 | (2,118) | 603 | | Interest Expense | 150 |
-
|
-
|
-
| | Income Before Tax | (267) | 413 | (2,118) | 603 | | Income Tax Expense | (222) | (42) | (648) | 34 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (45) | 455 | (1,470) | 569 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (45) | 455 | (1,470) | 569 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($45) | $455 | ($1,470) | $569 |
|
0.01% Nasdaq 
Income Statement
